导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.11% | 63/76 |
| 近一周 | -2.34% | 72/86 |
| 近一月 | -5.03% | 70/85 |
| 近一季 | 1.28% | 20/85 |
| 近半年 | -4.37% | 65/78 |
| 近一年 | -12.61% | 66/74 |
| 近两年 | 12.01% | 66/69 |
| 近三年 | 10.72% | 56/62 |
| 成立以来 | 127.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.90% 66/76 |
0.97% 68/85 |
- - |
- - |
| 2025 | 8.48% 70/76 |
1.76% 29/74 |
-0.18% 70/74 |
15.36% 44/74 |
-7.43% 65/76 |
| 2024 | 3.50% 58/75 |
5.23% 37/67 |
1.33% 48/72 |
10.81% 13/74 |
-12.41% 72/75 |
| 2023 | 10.47% 17/72 |
1.39% 33/57 |
-6.61% 46/64 |
6.64% 4/68 |
9.40% 21/72 |
| 2022 | -18.22% 20/46 |
-12.95% 25/43 |
-1.45% 15/45 |
-15.29% 34/45 |
12.54% 7/46 |
| 2021 | 5.99% 13/43 |
-5.45% 290/312 |
5.48% 133/328 |
-3.09% 171/358 |
9.67% 5/43 |
| 2020 | 35.82% 14/41 |
-3.22% 49/280 |
27.16% 64/295 |
13.42% 22/299 |
-2.70% 280/305 |
| 2019 | 31.97% 2/35 |
16.83% 34/258 |
1.65% 127/268 |
-0.27% 155/253 |
11.43% 44/266 |
| 2018 | -12.97% 9/31 |
- - |
- - |
- - |
-17.24% 194/241 |
| 2017 | 38.68% 4/30 |
- - |
- - |
- - |
- - |
| 2016 | -1.05% 18/31 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 平安港股医疗优选股票(QDII)A | 0.9556 | 19.76% |
| 平安港股医疗优选股票(QDII)C | 0.9520 | 18.70% |
| 诺安油气能源 | 1.4510 | 13.79% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5491 | 9.61% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5285 | 9.47% |
| 宏利印度股票(QDII) | 1.3394 | 3.49% |
| 宏利印度股票(QDII)C | 1.3360 | 3.41% |
| 长城港股价值优选股票(QDII)A | 0.9773 | 1.91% |
| 长城港股价值优选股票(QDII)C | 0.9755 | 1.82% |
| 华宝海外科技股票(QDII-LOF)A | 2.3598 | 1.69% |
| 嘉实全球互联网股票人民币 VS. 华宝海外科技股票(QDII(501312) |